Invo Fertility Inc (IVF) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Invo Fertility Inc   (IVF)

Select the Financial Report: Select the Period:


Description of Invo Fertility Inc's Business Segments
The registrant operates through three reportable business segments: Clinic Services, INVOcell Device, and Therapeutics. The Clinic Services segment comprises financial information for WFI and the Atlanta Clinic. The INVOcell Device segment involves the manufacture and sales of the INVOcell device. The Therapeutics segment pertains to the subsidiary NTI, which was 80.1% divested during the second quarter of 2025; therefore, this segment includes NTI's results only through June 2, 2025. All operations and sales occur within the United States. Segment financials for 2025 and 2024 include revenues, costs, expenses, impairments, depreciation, and segment profits or losses, with reconciliations to income before taxes. No single customer accounted for 10% or more of consolidated revenues or trade accounts receivable in 2025 or 2024.

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Composition of Invo Fertility Inc Revenues by Segments
 
Product    1.89 % of total Revenue
Clinic Revenue    190.8 % of total Revenue
Revenue From External Customers    192.69 % of total Revenue
Member    192.69 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)		 %
(of total Revenues)
Product 0.04 1.89 %
Clinic Revenue 4.15 190.8 %
Revenue From External Customers 4.19 192.69 %
Member 4.19 192.69 %
Total 2.18 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%		 Q/Q Revenue
%
Product - 24.24 %
Clinic Revenue - 109.38 %
Revenue From External Customers - 107.78 %
Member - 107.78 %
Total 16.71 % 7.94 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)		 %
(Profit Margin)
Total 0.89 40.87 %




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%		 Q/Q Income
%
Total - -




Annual Report on Invo Fertility Inc Divisions, Sales by Country

 


Twelve months ended 2025
IVF s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Total 6.84 100 %


Twelve months ended 2025
IVF s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -23.32 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Revenue From External Customers - -
Total 4.73 % -
Inter Revenue - -
Fertility Clinic Services - -
Fertility Clinic Services Revenue From External Customers - -
Invocell Device - -
Invocell Device Revenue From External Customers - -
Invocell Device Inter Revenue - -
Other Segment - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.